Portfolio: AI-Powered Solutions for Pharmaceutical R&D

Portfolio: AI-Powered Solutions for Pharmaceutical R&D

PHAARM MatchMaker

Overview:

PHAARM MatchMaker is an innovative digital product that utilizes polypharmacology technology and artificial intelligence to bridge the gap between chemistry and biology in drug discovery.

Features & Benefits:

  • Establishes "molecular and biological signature" patterns, creating a comprehensive multi-biological profile of a drug's response to a disease.
  • Enhances therapy exploration, scaffold hopping, and preclinical toxicology prediction.
  • Facilitates pharmacokinetic comparison, anticipation of drug-drug interactions, and discovery of drug repurposing opportunities.

RDrug

Overview:

RDrug is an AI-powered application designed to discover new therapeutic applications for drugs. It utilizes a proprietary "molecular and biological signatures" technology for drug repositioning.

Features & Benefits:

  • Helps to differentiate products from generics and protect them against competitors.
  • Accelerates development by an estimated 40% and reduces program duration by 1-3 years.

Detoxie for ICH M7

Overview:

Detoxie for ICH M7 is an AI-powered product designed for advanced mutagenicity and carcinogenicity risk assessment in the pharmaceutical industry. It evaluates a product's physicochemical and biopharmaceutical properties in line with ICH M7 guidelines.

Features & Benefits:

  • Predicts and assesses the mutagenic potential of drug impurities to facilitate compliance with ICH M7 regulations.
  • Aligns with international acceptance standards recommended by the OECD, ensuring reliability and security for technical-scientific reports.

ReactorSim

Overview:

ReactorSim is an innovative suite of software solutions designed to transform the API manufacturing and pharmaceutical industries, providing robust analysis of nitrosamine formation and its potential mutagenic and carcinogenic implications.

Features & Benefits:

  • Offers quantitative assessment of N-nitrosamine and nitrosamide drug substance-related impurities (NDSRIs).
  • Utilizes advanced stoichiometric calculations and worst-case kinetic mathematical models for accurate product yield analysis.
  • Employs AI and image recognition technology for regulatory compliance by transforming images into editable molecular structures.

PurgeSafe® (Upcoming Product)

Overview:

PurgeSafe® is a future product designed to standardize the process of determining purge factors for potentially mutagenic impurities in drug substance synthesis.

Features & Benefits:

  • Offers a methodical approach to calculating reactivity purge factors and a comprehensive management strategy for PMIs.
  • Uses AI to predict reactivity, calculate volatility purges, and streamline purge factor calculations.
  • Provides a thorough report with predicted purge calculations, scientific justification, and supporting data, enhancing regulatory submissions.

Skills & Expertise:

  • Strong leadership and project management skills: Successfully led the development and launch of multiple high-impact digital products.
  • Deep expertise in AI and pharmaceutical R&D: Applied artificial intelligence in practical solutions addressing complex problems in the pharmaceutical industry.
  • Focus on customer satisfaction and business success: Maintained close collaboration with clients to understand their unique requirements, ensuring products exceed expectations and deliver tangible value.
  • Adaptability and innovation: Continually involved in the development of innovative products and solutions for research and development purposes.

The provided details demonstrate a robust portfolio with a track record of innovation and successful product launches. Each product shows the application of AI in solving significant challenges in the pharmaceutical industry, showcasing expertise in AI, project management, and customer satisfaction.